The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration issued joint warning letters to operators of two websites illegally selling Schedule II stimulants, including amphetamine drug products marketed as Adderall. These websites sell Adderall online without a prescription, which places consumers at risk.
The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) is interested in how social media affects the public’s perception of drugs.
Mylan has come under fire from the U.S. Food and Drug Administration over inadequate good manufacturing practices at one of the company’s drug manufacturing facilities in India.
India’s ability to produce affordable generic drugs has led to the country’s reputation of being the “pharmacy of the world,” according to Dr. Reddy’s Vice President Radha Iyer.
Pfizer Inc. received a request for documents as part of a U.S. investigation related to quality issues involving the manufacture of auto-injectors at the company’s Meridian Medical Technologies site.
The U.S. Food and Drug Administration sent warning letters to nine online networks operating a total of 53 websites to stop illegally marketing unapproved versions of opioid medications.
Mylan N.V.’s emergency allergy antidote EpiPen is in short supply in Canada and Britain, but remains available in the United States, the treatment’s manufacturer said.
The U.S. Food and Drug Administration issued a warning letter to Becton Dickinson (BD) & Company that cited several violations of federal law.